Relay Therapeutics, Inc. (RLAY) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $15.36M | +53.4% |
| 2024 | $10.01M | -60.8% |
| 2023 | $25.55M | +1749.8% |
| 2022 | $1.38M | -54.4% |
| 2021 | $3.03M | -96.3% |
| 2020 | $82.65M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $15.36M | +53.4% |
| 2024 | $10.01M | -60.8% |
| 2023 | $25.55M | +1749.8% |
| 2022 | $1.38M | -54.4% |
| 2021 | $3.03M | -96.3% |
| 2020 | $82.65M | — |